 Corey Lyon
Concepts (234)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Physicians, Family | 2 | 2022 | 195 | 1.150 |
Why?
| | Anticoagulants | 2 | 2025 | 667 | 1.040 |
Why?
| | Osteoarthritis, Knee | 2 | 2018 | 256 | 0.900 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2024 | 2490 | 0.890 |
Why?
| | Hypertension | 4 | 2022 | 1242 | 0.880 |
Why?
| | Glucocorticoids | 3 | 2018 | 528 | 0.830 |
Why?
| | Venous Thrombosis | 1 | 2025 | 190 | 0.810 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 2 | 2021 | 68 | 0.790 |
Why?
| | Medical Staff | 2 | 2022 | 17 | 0.790 |
Why?
| | Uterine Cervical Neoplasms | 2 | 2020 | 282 | 0.780 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2024 | 103 | 0.750 |
Why?
| | Metformin | 2 | 2023 | 331 | 0.720 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2021 | 1045 | 0.720 |
Why?
| | Sphygmomanometers | 1 | 2021 | 6 | 0.710 |
Why?
| | Papillomavirus Infections | 2 | 2020 | 377 | 0.710 |
Why?
| | Insulin, Isophane | 1 | 2021 | 21 | 0.700 |
Why?
| | Automation | 1 | 2021 | 99 | 0.680 |
Why?
| | Humans | 56 | 2025 | 138651 | 0.680 |
Why?
| | Insulin Glargine | 1 | 2021 | 84 | 0.670 |
Why?
| | Prediabetic State | 1 | 2023 | 248 | 0.660 |
Why?
| | Employment | 1 | 2022 | 181 | 0.650 |
Why?
| | Blood Pressure Determination | 1 | 2021 | 143 | 0.650 |
Why?
| | Preventive Health Services | 1 | 2022 | 152 | 0.640 |
Why?
| | Early Detection of Cancer | 2 | 2022 | 426 | 0.640 |
Why?
| | Analgesia, Obstetrical | 1 | 2020 | 31 | 0.640 |
Why?
| | Aspirin | 2 | 2020 | 385 | 0.640 |
Why?
| | Smoking Cessation | 1 | 2024 | 436 | 0.640 |
Why?
| | Ganglion Cysts | 1 | 2020 | 10 | 0.640 |
Why?
| | Analgesia, Epidural | 1 | 2020 | 40 | 0.630 |
Why?
| | Post-Concussion Syndrome | 1 | 2023 | 180 | 0.630 |
Why?
| | Papillomaviridae | 1 | 2020 | 133 | 0.620 |
Why?
| | Anti-Bacterial Agents | 2 | 2021 | 1818 | 0.620 |
Why?
| | C-Reactive Protein | 2 | 2021 | 415 | 0.610 |
Why?
| | Wrist | 1 | 2020 | 57 | 0.610 |
Why?
| | Spironolactone | 1 | 2019 | 34 | 0.600 |
Why?
| | Diuretics | 1 | 2019 | 72 | 0.600 |
Why?
| | Memory | 1 | 2021 | 258 | 0.590 |
Why?
| | Probiotics | 1 | 2019 | 56 | 0.590 |
Why?
| | Ketorolac | 1 | 2019 | 25 | 0.590 |
Why?
| | Glucosamine | 1 | 2018 | 15 | 0.590 |
Why?
| | Erythromycin | 1 | 2018 | 20 | 0.570 |
Why?
| | Rh-Hr Blood-Group System | 1 | 2018 | 14 | 0.570 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 2 | 2019 | 347 | 0.570 |
Why?
| | Glycemic Index | 1 | 2018 | 26 | 0.560 |
Why?
| | Viscosupplements | 1 | 2018 | 11 | 0.560 |
Why?
| | Ureteral Calculi | 1 | 2018 | 12 | 0.560 |
Why?
| | Sweating | 1 | 2018 | 41 | 0.550 |
Why?
| | Acute Pain | 1 | 2019 | 51 | 0.550 |
Why?
| | Musculoskeletal System | 1 | 2018 | 49 | 0.540 |
Why?
| | Hot Flashes | 1 | 2018 | 87 | 0.520 |
Why?
| | Antibiotic Prophylaxis | 1 | 2018 | 121 | 0.520 |
Why?
| | Testosterone | 1 | 2021 | 402 | 0.520 |
Why?
| | Patient Education as Topic | 2 | 2022 | 766 | 0.520 |
Why?
| | Obstetric Labor, Premature | 1 | 2017 | 39 | 0.520 |
Why?
| | Prenatal Diagnosis | 1 | 2018 | 188 | 0.500 |
Why?
| | Labor, Obstetric | 1 | 2017 | 66 | 0.500 |
Why?
| | Warfarin | 1 | 2017 | 153 | 0.500 |
Why?
| | Family Practice | 2 | 2018 | 463 | 0.490 |
Why?
| | Hypoglycemia | 1 | 2021 | 460 | 0.490 |
Why?
| | Athletic Injuries | 1 | 2023 | 517 | 0.490 |
Why?
| | Telemedicine | 2 | 2022 | 873 | 0.490 |
Why?
| | Melatonin | 1 | 2017 | 154 | 0.480 |
Why?
| | Factor Xa Inhibitors | 1 | 2017 | 170 | 0.480 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2017 | 105 | 0.480 |
Why?
| | Carpal Tunnel Syndrome | 1 | 2016 | 28 | 0.480 |
Why?
| | Methylprednisolone | 1 | 2016 | 63 | 0.480 |
Why?
| | Analgesics | 1 | 2018 | 225 | 0.480 |
Why?
| | Job Satisfaction | 1 | 2018 | 218 | 0.480 |
Why?
| | Hyaluronic Acid | 1 | 2018 | 226 | 0.470 |
Why?
| | Migraine Disorders | 1 | 2017 | 105 | 0.470 |
Why?
| | Practice Guidelines as Topic | 4 | 2020 | 1567 | 0.470 |
Why?
| | Acute Coronary Syndrome | 1 | 2019 | 279 | 0.470 |
Why?
| | Randomized Controlled Trials as Topic | 7 | 2023 | 1518 | 0.470 |
Why?
| | Brain Concussion | 1 | 2023 | 579 | 0.460 |
Why?
| | Menopause | 1 | 2018 | 316 | 0.450 |
Why?
| | Colorectal Neoplasms | 1 | 2022 | 777 | 0.430 |
Why?
| | Cough | 1 | 2015 | 125 | 0.420 |
Why?
| | Drug Administration Schedule | 3 | 2025 | 768 | 0.420 |
Why?
| | Patient Care Team | 2 | 2018 | 647 | 0.410 |
Why?
| | Adrenal Cortex Hormones | 1 | 2017 | 496 | 0.410 |
Why?
| | Exercise Therapy | 1 | 2018 | 439 | 0.410 |
Why?
| | Antioxidants | 1 | 2017 | 593 | 0.400 |
Why?
| | Respiratory Tract Diseases | 1 | 2015 | 181 | 0.400 |
Why?
| | Myofascial Pain Syndromes | 2 | 2023 | 12 | 0.400 |
Why?
| | Insulin | 1 | 2024 | 2448 | 0.400 |
Why?
| | Acupuncture Therapy | 2 | 2023 | 22 | 0.390 |
Why?
| | Mass Screening | 2 | 2022 | 1292 | 0.390 |
Why?
| | Atrial Fibrillation | 1 | 2017 | 377 | 0.390 |
Why?
| | Virus Diseases | 1 | 2015 | 214 | 0.380 |
Why?
| | Behavior Therapy | 3 | 2023 | 273 | 0.370 |
Why?
| | Low Back Pain | 2 | 2023 | 107 | 0.360 |
Why?
| | Health Promotion | 1 | 2018 | 750 | 0.350 |
Why?
| | Cardiovascular Diseases | 2 | 2020 | 2053 | 0.340 |
Why?
| | Pain Measurement | 4 | 2023 | 548 | 0.320 |
Why?
| | Aged, 80 and over | 7 | 2021 | 7677 | 0.320 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2020 | 139 | 0.280 |
Why?
| | Aged | 10 | 2021 | 24024 | 0.280 |
Why?
| | Depression | 1 | 2017 | 1466 | 0.270 |
Why?
| | Organizational Innovation | 2 | 2019 | 138 | 0.270 |
Why?
| | Female | 16 | 2023 | 73763 | 0.270 |
Why?
| | Abdomen, Acute | 1 | 2006 | 22 | 0.260 |
Why?
| | Pregnancy | 4 | 2022 | 6829 | 0.260 |
Why?
| | Azithromycin | 2 | 2018 | 97 | 0.260 |
Why?
| | Papillomavirus Vaccines | 1 | 2010 | 318 | 0.250 |
Why?
| | Middle Aged | 11 | 2021 | 33604 | 0.240 |
Why?
| | Enuresis | 1 | 2005 | 3 | 0.240 |
Why?
| | Deamino Arginine Vasopressin | 1 | 2005 | 13 | 0.240 |
Why?
| | Renal Agents | 1 | 2005 | 5 | 0.240 |
Why?
| | Treatment Outcome | 7 | 2021 | 10923 | 0.240 |
Why?
| | Adult | 9 | 2022 | 38201 | 0.210 |
Why?
| | Hormone Replacement Therapy | 2 | 2023 | 99 | 0.210 |
Why?
| | Fibromyalgia | 1 | 2023 | 53 | 0.200 |
Why?
| | Vaping | 1 | 2024 | 61 | 0.200 |
Why?
| | Age Factors | 2 | 2022 | 3256 | 0.190 |
Why?
| | Electronics | 1 | 2023 | 72 | 0.190 |
Why?
| | Naltrexone | 1 | 2023 | 102 | 0.190 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2019 | 2049 | 0.190 |
Why?
| | Occult Blood | 1 | 2022 | 34 | 0.180 |
Why?
| | Evidence-Based Medicine | 4 | 2019 | 745 | 0.180 |
Why?
| | Hypoglycemic Agents | 2 | 2024 | 1341 | 0.180 |
Why?
| | Lipid Regulating Agents | 1 | 2020 | 2 | 0.170 |
Why?
| | Postmenopause | 1 | 2023 | 370 | 0.170 |
Why?
| | United States | 5 | 2022 | 14938 | 0.170 |
Why?
| | Life Style | 1 | 2023 | 478 | 0.170 |
Why?
| | Fish Oils | 1 | 2020 | 26 | 0.170 |
Why?
| | Time Factors | 2 | 2023 | 6851 | 0.170 |
Why?
| | Hypertriglyceridemia | 1 | 2020 | 39 | 0.170 |
Why?
| | Labor Stage, Second | 1 | 2020 | 3 | 0.170 |
Why?
| | Prenatal Care | 1 | 2022 | 295 | 0.160 |
Why?
| | Carcinoma, Basal Cell | 1 | 2020 | 71 | 0.160 |
Why?
| | Inpatients | 1 | 2024 | 502 | 0.160 |
Why?
| | Colonoscopy | 1 | 2022 | 243 | 0.150 |
Why?
| | Delivery, Obstetric | 1 | 2020 | 159 | 0.150 |
Why?
| | Ticlopidine | 1 | 2019 | 52 | 0.150 |
Why?
| | Systems Integration | 1 | 2018 | 38 | 0.150 |
Why?
| | Pain Management | 2 | 2023 | 389 | 0.150 |
Why?
| | Chondroitin Sulfates | 1 | 2018 | 31 | 0.140 |
Why?
| | Rho(D) Immune Globulin | 1 | 2018 | 5 | 0.140 |
Why?
| | Primary Prevention | 1 | 2020 | 200 | 0.140 |
Why?
| | Venlafaxine Hydrochloride | 1 | 2018 | 14 | 0.140 |
Why?
| | Netherlands | 1 | 2018 | 87 | 0.140 |
Why?
| | Primary Health Care | 2 | 2019 | 1777 | 0.140 |
Why?
| | Clostridium Infections | 1 | 2019 | 73 | 0.140 |
Why?
| | Proton Pump Inhibitors | 1 | 2019 | 108 | 0.140 |
Why?
| | Arthralgia | 1 | 2018 | 54 | 0.140 |
Why?
| | Pneumonia, Bacterial | 1 | 2019 | 114 | 0.140 |
Why?
| | Male | 9 | 2021 | 68260 | 0.140 |
Why?
| | Citalopram | 1 | 2018 | 35 | 0.140 |
Why?
| | Visual Analog Scale | 1 | 2018 | 35 | 0.140 |
Why?
| | Injections, Intra-Articular | 1 | 2018 | 58 | 0.140 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 392 | 0.140 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2018 | 50 | 0.140 |
Why?
| | Yoga | 1 | 2018 | 32 | 0.140 |
Why?
| | Patients | 1 | 2019 | 180 | 0.140 |
Why?
| | Prurigo | 1 | 2016 | 2 | 0.130 |
Why?
| | Estrogen Replacement Therapy | 1 | 2018 | 140 | 0.130 |
Why?
| | Community-Acquired Infections | 1 | 2019 | 173 | 0.130 |
Why?
| | Pain | 2 | 2023 | 777 | 0.130 |
Why?
| | Regression Analysis | 1 | 2019 | 1017 | 0.130 |
Why?
| | Blood Glucose | 2 | 2024 | 2239 | 0.130 |
Why?
| | Nonprescription Drugs | 1 | 2017 | 63 | 0.130 |
Why?
| | Sulfonylurea Compounds | 1 | 2017 | 48 | 0.130 |
Why?
| | Dipeptidyl-Peptidase IV Inhibitors | 1 | 2017 | 47 | 0.130 |
Why?
| | Recurrence | 1 | 2020 | 1084 | 0.120 |
Why?
| | Dietary Supplements | 1 | 2020 | 553 | 0.120 |
Why?
| | Gastroesophageal Reflux | 1 | 2019 | 242 | 0.120 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 444 | 0.120 |
Why?
| | Smoking | 1 | 2024 | 1591 | 0.120 |
Why?
| | Exanthema | 1 | 2016 | 80 | 0.120 |
Why?
| | Psychiatry | 1 | 2018 | 187 | 0.120 |
Why?
| | Prednisone | 1 | 2016 | 227 | 0.120 |
Why?
| | Sleep | 1 | 2022 | 799 | 0.120 |
Why?
| | Administration, Oral | 1 | 2018 | 788 | 0.120 |
Why?
| | Injections | 1 | 2016 | 189 | 0.120 |
Why?
| | Hemorrhage | 1 | 2020 | 747 | 0.110 |
Why?
| | Diabetic Foot | 1 | 2015 | 24 | 0.110 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2019 | 469 | 0.110 |
Why?
| | Acute Disease | 1 | 2018 | 994 | 0.110 |
Why?
| | Achilles Tendon | 1 | 2015 | 31 | 0.110 |
Why?
| | Adolescent | 2 | 2025 | 21564 | 0.110 |
Why?
| | Burnout, Professional | 2 | 2019 | 448 | 0.110 |
Why?
| | Health Status | 1 | 2020 | 819 | 0.110 |
Why?
| | Tendon Injuries | 1 | 2015 | 67 | 0.110 |
Why?
| | Quality of Health Care | 1 | 2019 | 654 | 0.110 |
Why?
| | Sulfonamides | 1 | 2018 | 505 | 0.110 |
Why?
| | Pandemics | 1 | 2022 | 1641 | 0.110 |
Why?
| | Hospitalization | 1 | 2024 | 2235 | 0.100 |
Why?
| | Treatment Failure | 1 | 2015 | 351 | 0.100 |
Why?
| | Drug Therapy, Combination | 1 | 2017 | 1032 | 0.100 |
Why?
| | Double-Blind Method | 1 | 2018 | 1949 | 0.100 |
Why?
| | Young Adult | 2 | 2023 | 13305 | 0.100 |
Why?
| | Gestational Age | 1 | 2017 | 916 | 0.100 |
Why?
| | Administration, Inhalation | 1 | 2015 | 595 | 0.100 |
Why?
| | Psychometrics | 1 | 2017 | 727 | 0.100 |
Why?
| | Skin Neoplasms | 1 | 2020 | 837 | 0.100 |
Why?
| | Osteomyelitis | 1 | 2015 | 139 | 0.100 |
Why?
| | Venous Thromboembolism | 1 | 2017 | 324 | 0.100 |
Why?
| | Child | 3 | 2025 | 21921 | 0.080 |
Why?
| | Alphapapillomavirus | 1 | 2010 | 39 | 0.080 |
Why?
| | Colorado | 2 | 2019 | 4555 | 0.080 |
Why?
| | Child, Preschool | 1 | 2025 | 11158 | 0.080 |
Why?
| | Mental Disorders | 1 | 2018 | 1096 | 0.080 |
Why?
| | Emergency Service, Hospital | 1 | 2019 | 2116 | 0.070 |
Why?
| | Prospective Studies | 1 | 2018 | 7554 | 0.060 |
Why?
| | Surveys and Questionnaires | 1 | 2017 | 5803 | 0.050 |
Why?
| | Diagnostic Imaging | 1 | 2006 | 320 | 0.050 |
Why?
| | Amitriptyline | 1 | 2023 | 22 | 0.050 |
Why?
| | Trigger Points | 1 | 2023 | 13 | 0.050 |
Why?
| | Blood Pressure | 2 | 2022 | 1739 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3637 | 0.050 |
Why?
| | Diagnosis, Differential | 1 | 2006 | 1482 | 0.050 |
Why?
| | Dermoscopy | 1 | 2020 | 10 | 0.040 |
Why?
| | Clinical Trials as Topic | 1 | 2005 | 1034 | 0.040 |
Why?
| | Antihypertensive Agents | 1 | 2022 | 505 | 0.040 |
Why?
| | Models, Organizational | 1 | 2019 | 147 | 0.040 |
Why?
| | Long-Term Care | 1 | 2019 | 105 | 0.040 |
Why?
| | Interdisciplinary Communication | 1 | 2018 | 191 | 0.030 |
Why?
| | Workflow | 1 | 2018 | 164 | 0.030 |
Why?
| | Survival Analysis | 1 | 2019 | 1309 | 0.030 |
Why?
| | Skin | 1 | 2020 | 754 | 0.030 |
Why?
| | Blood Sedimentation | 1 | 2015 | 40 | 0.030 |
Why?
| | Rupture | 1 | 2015 | 88 | 0.030 |
Why?
| | Foot | 1 | 2015 | 99 | 0.030 |
Why?
| | Mental Health Services | 1 | 2018 | 433 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2016 | 608 | 0.030 |
Why?
| | Comorbidity | 1 | 2018 | 1656 | 0.030 |
Why?
| | Radiography | 1 | 2015 | 841 | 0.020 |
Why?
| | Prevalence | 1 | 2019 | 2727 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 3984 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2015 | 1941 | 0.020 |
Why?
| | Quality Improvement | 1 | 2018 | 1213 | 0.020 |
Why?
| | Risk Assessment | 1 | 2019 | 3433 | 0.020 |
Why?
| | Infant | 1 | 2022 | 9574 | 0.020 |
Why?
| | Risk Factors | 1 | 2017 | 10252 | 0.010 |
Why?
|
|
Lyon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|